XML 30 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Consolidated Statements Of Operations [Abstract]      
Product revenues $ 369,588 $ 112,403 $ 60,925
Cost of sales 274,841 79,664 45,166
Gross margin 94,747 32,739 15,759
Operating costs and expenses:      
Research and development expenses 29,372 11,922 8,097
Reimbursed research and development expenses (932) (2,269) (2,103)
Net research and development expenses 28,440 9,653 5,994
Acquisition transaction expenses 5,316    
Selling, general and administrative expenses 42,110 10,955 8,857
Total operating costs and expenses 75,866 20,608 14,851
Operating income 18,881 12,131 908
Interest income (expense) (3,511) 25 10
Debt retirement expense (1,160)    
Revaluation of derivatives (6,118)    
Foreign currency gain 9,207    
Loss from equity investment (243) (22) (492)
Other income (114) 145 183
Earnings before income tax 16,942 12,279 609
Income tax expense 5,053 2,921 325
Net income 11,889 9,358 284
(Income) loss attributable to non-controlling interest (1,545) 592 439
Net income attributable to Amerigon, Inc. 10,344 9,950 723
Convertible preferred stock dividends (8,228)    
Net income (loss) attributable to common shareholders $ 2,116 $ 9,950 $ 723
Basic earnings per share $ 0.09 $ 0.46 $ 0.03
Diluted earnings per share $ 0.09 $ 0.44 $ 0.03
Weighted average number of shares - basic 22,606 21,717 21,402
Weighted average number of shares - diluted 23,455 22,496 21,771